Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel HDAC inhibitors prepared and tested by 4SC and G2M scientists

March 3, 2004

Reolysin program update

March 3, 2004

Genzyme to acquire Ilex Oncology

March 3, 2004

Three series of antitumor epothilones described by GBF and Morphochem researchers

March 2, 2004

Novel proapoptotic IAP-binding agents identified at Princeton University

March 2, 2004

Lower risk for Hodgkin's lymphoma reported to be associated with aspirin use

March 2, 2004

Good pharmacological profile and antitumor activity of topoisomerase I-active agent BMS-251873

March 2, 2004

Avastin approved for first-line metastatic colorectal cancer

March 1, 2004

Abraxane enters new studies in NSCLC and metastatic melanoma

March 1, 2004

Pharmacia claims new protein kinase inhibitors for cancer and other disorders

March 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026